Christophe Schilling

Christophe Heinz Schilling is a highly accomplished professional with a diverse educational background and rich experience in the biotechnology industry.

He pursued his high school education at Grosse Pointe South High School, followed by a Bachelor of Science in Engineering in Biomedical Engineering from Duke University.

Driven by his passion for research and innovation, Christophe furthered his academic journey by earning a Doctor of Philosophy in Bioengineering from UC San Diego.

With a strong foundation in both engineering and bioengineering, Christophe Heinz Schilling has held prominent leadership positions in various prestigious organizations.

Currently, he serves as the Chief Executive Officer at Genomatica, where he leads the company's strategic vision and growth initiatives.

Prior to his role at Genomatica, Christophe was actively involved in shaping the direction of the biotechnology industry through his contributions as a Board of Directors member at Biocom.

His expertise and leadership skills were further demonstrated during his tenure as a Board of Directors member at GT Life Sciences, Inc., showcasing his strategic acumen and industry knowledge.

Christophe Heinz Schilling's academic achievements and professional accomplishments reflect his commitment to advancing the field of biotechnology and driving innovation in the industry.